Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Nice finish with chunk of 0.24s taken out

<< Previous

Bullboard Posts

Next >>

Comment by Oden6570on Sep 08, 2021 9:27am

504 Views

Post# 33824139

RE:RE:RE:RE:Nice finish with chunk of 0.24s taken out

DJDawg wrote: I'm not overly familiar with how warrants work. As shareholders right now, is it a good thing for us for the warrants to expire vs exercised?

If you recall TLT mgt extended recent expiring warrants, As Covid is still IMHO effecting Theralase negatively ( trial delays , laser sales ) I would imagine they would do the same for any due in the near future. We have cash for 1 to 1.5 years currently.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December